by GlobeNewsWire | Aug 9, 2016 | Globe Newswire
Significant Progress with EU Galafold Launch and Regulatory Submissions Enrollment in Pompe Phase 1/2 Clinical Study on Track with Initial Data Expected in 2H16 Elevation of “Time to Wound Closure” as Co-Primary Endpoint in Ongoing Phase 3 Study of SD-101 for...
by GlobeNewsWire | Aug 8, 2016 | Globe Newswire
— Second-Quarter 2016 Record Net Sales of $257.4 Million, Up 49 Percent —- Second-Quarter 2016 GAAP Net Income of $15.0 Million; Adjusted EBITDA of $121.1 Million —- Confirms Full-Year 2016 Net Sales Guidance of $1.025 to $1.050 Billion and Full-Year...
by GlobeNewsWire | Jul 8, 2016 | Globe Newswire
NEW YORK, July 08, 2016 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Chiasma, Inc. (“Chiasma” or the “Company”) (NASDAQ:CHMA) and certain of its officers. The class action, filed in United States District Court,...
by GlobeNewsWire | Jun 14, 2016 | Globe Newswire
NOVATO, Calif., June 14, 2016 (GLOBE NEWSWIRE) — Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will participate in the following investor conference:Julie Anne Smith, President and Chief Executive Officer, will participate in a fireside chat...
by GlobeNewsWire | Jun 7, 2016 | Globe Newswire
GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 07, 2016 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of...